SlideShare uma empresa Scribd logo
1 de 13
Baixar para ler offline
PATENT LITIGATION ANALYSIS
by
www.maxval.com
Los Altos, CA
Pharma & Biotech patent litigation analysis 2
0
100
200
300
400
500
600
700
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
No. of cases Filed
No. of cases Closed
Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
No. of cases filed 166 140 179 294 283 328 424 381 451 622 584
No. of cases closed 109 118 119 206 245 278 343 417 422 535 605
PHARMA & BIOTECH PATENT LAWSUIT OVERVIEW 2004-2014
Pharma & Biotech patent litigation analysis 3
Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
Pharma & Biotech Patent
Lawsuits Filed
166 140 179 294 283 328 424 381 451 622 584
Total Patent Lawsuits Filed 2810 2565 2636 2794 2643 2580 3354 3907 5466 6107 5016
PHARMA & BIOTECH VS. OVERALL LITIGATION
0
1000
2000
3000
4000
5000
6000
7000
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
No. of Pharma & Biotech Patent Lawsuits Filed Total no. of Patent Lawsuits Filed
Pharma & Biotech patent litigation analysis 4
6%
5%
7%
11% 11%
13% 13%
10%
8%
10%
12%
0%
2%
4%
6%
8%
10%
12%
14%
2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014
PERCENTAGE OF PHARMA & BIOTECH LITIGATION CASES 2004-2014
Pharma & Biotech patent litigation analysis 5
0
5
10
15
20
25
30
35
40
45
50
Top plaintiff No. of cases
Novartis Pharmaceuticals Corp. 47
Otsuka Pharmaceutical Co., Ltd. 35
AstraZeneca AB 32
Pfizer, Inc. 30
The Tawnsaura Group, LLC 26
AbbVie, Inc. 22
Cephalon, Inc. 22
Thermolife International, LLC 22
Warner Chilcott Company, LLC 21
Eli Lilly and Company 19
TOP COMPANIES AS PLAINTIFF
Pharma & Biotech patent litigation analysis 6
0
5
10
15
20
25
30
35
40
45
Top defendant No. of cases
Mylan, Inc. 43
Watson Laboratories, Inc. 35
Actavis Elizabeth, LLC 30
Lupin, Ltd. 28
Sandoz, Inc. 26
Apotex Corp. 24
Amneal Pharmaceuticals, LLC 23
Par Pharmaceutical, Inc. 22
Aurobinda Pharma, Ltd. 19
Roxane Laboratories, Inc. 18
TOP COMPANIES AS DEFENDANT
Pharma & Biotech patent litigation analysis 7
Following are the details of the court wise case filings by Pharma & Biotech companies in the year 2014
0
50
100
150
200
250
California
Central
California
Northern
Delaware Florida
Southern
Illinois
Northern
Indiana
Southern
Massachu
setts
Michigan
Eastern
New
Jersey
New York
Southern
Texas
Eastern
West
Virginia
Northern
Utah Rest of
the
Courts
No. of Cases 18 7 216 10 11 12 10 10 156 29 9 11 12 73
3%
1%
37%
2% 2% 2% 2% 2%
27%
5%
1% 2% 2%
12%
COURT-WISE NEW CASES FILED IN 2014
Pharma & Biotech patent litigation analysis 8
Following are the details of the court wise case closures by Pharma & Biotech companies in the year 2014
0
20
40
60
80
100
120
140
160
180
California
Central
California
Northern
California
Southern
Delaware Florida
Southern
Illinois
Northern
Indiana
Southern
Massachu
setts
Nevada New
Jersey
New York
Southern
Virginia
Eastern
Texas
Eastern
Rest of
the
Courts
No. of Cases 50 13 19 162 11 10 8 13 8 113 40 43 23 92
8%
2%
3%
27%
2% 2% 1%
2%
1%
19%
7% 7%
4%
15%
COURT-WISE CLOSED CASES IN 2014
Pharma & Biotech patent litigation analysis 9
0
50
100
150
200
250
300
350
400
450
2014 Filed 2014 Closed
Midwest 51 45
Northeast 422 341
South East 53 86
South West 16 34
West 42 99
REGION-WISE FILED & CLOSED CASES IN 2014
Pharma & Biotech patent litigation analysis 10
0
20
40
60
80
100
120
140
160
180
200
Top Plaintiff Lawfirm 2014 cases
0
5
10
15
20
25
30
35
Top Defendant Lawfirm 2014 cases
Plaintiff's Lawfirm No. of cases
Morris, Nichols, Arsht & Tunnell, LLP 177
Mccarter & English, LLP 92
Pepper Hamilton, LLP 55
Ashby & Geddes 25
Saul Ewing, LLP 23
Shaw Keller, LLP 22
Fish & Richardson, PC 21
Newport Trial Group 19
Barnes & Thornburg, LLP 18
Robinson, Wettre & Miller, LLC 17
Defendant's Lawfirm No. of cases
Potter Anderson & Corroon, LLP 31
Richards, Layton & Finger, PA 22
Young Conaway Stargatt & Taylor, LLP 19
Budd Larner, PC 15
Phillips, Goldman & Spence, PA 14
Connell Foley, LLP 13
Fish & Richardson, PC 9
Fox Rothschild, LLP 9
Hill Wallack, LLP 8
Saiber, LLC 8
TOP LAWFIRMS HANDLING PHARMA & BIOTECH LAWSUITS
Pharma & Biotech patent litigation analysis 11
Please contact us at bd@maxval-ip.com for detailed/comprehensive reports which
will also include the following analysis:
• Outcome of closed cases
• Settlements
• Judgments
• Dismissals
• Transfer of cases
• Damages
• Injunctions
• Winning and losing party
• Cases appealed in Federal Circuit (CAFC)
• ITC case details
• Supreme court case details
CONTACT US FOR DETAILED ANALYSIS
Pharma & Biotech patent litigation analysis 12
MaxVal’s Patent Litigation Databank, Analytics & API
 Litigation databank contains patent litigations filed since 1980.
 67,000+ cases in databank with daily updates.
 Fully searchable databases with information related to patent litigation from ECFs, PACER, ITC, etc.
 Complaints, docket reports, patent, product details, and patent file histories.
 Watch Case by patent, product, party, inventor etc.
 Outcome of the closed cases, such as settlements, dismissals, judgments etc.
 Litigation daily alerts.
 Patent litigation data analytics & research services.
 API - Integrate litigation data to your internal patent database/tools for analytics purpose and mapping of
litigation information to your study.
DATA SOURCE
Pharma & Biotech patent litigation analysis
MaxVal Group, Inc.
2251 Grant Road, Los Altos, CA 94024
Phone: 650-472-0644 Fax: 650-625-0294
Email: bd@maxval.com Web: www.maxval.com
SEEWhat Else We Can Do For
YOU
13
Need the full report?
(or)
Similar reports on patent litigation of your interest?
Please contact us at bd@maxval.com

Mais conteúdo relacionado

Mais procurados

Country study: Availability of essential medicines
Country study: Availability of essential medicines Country study: Availability of essential medicines
Country study: Availability of essential medicines Arete-Zoe, LLC
 
Essential medicines in Hungary
Essential medicines in Hungary Essential medicines in Hungary
Essential medicines in Hungary Arete-Zoe, LLC
 
PSM Interchange 2014: Scott LaGanga, Welcome to the 2014 Interchange
PSM Interchange 2014: Scott LaGanga, Welcome to the 2014 InterchangePSM Interchange 2014: Scott LaGanga, Welcome to the 2014 Interchange
PSM Interchange 2014: Scott LaGanga, Welcome to the 2014 InterchangeThe Partnership For Safe Medicines
 
Dave Aronberg: "Profiteers of Tragedy: Making Money Off America’s Opioid Addi...
Dave Aronberg: "Profiteers of Tragedy: Making Money Off America’s Opioid Addi...Dave Aronberg: "Profiteers of Tragedy: Making Money Off America’s Opioid Addi...
Dave Aronberg: "Profiteers of Tragedy: Making Money Off America’s Opioid Addi...reportingonhealth
 
The Skeeterhawk Experiment 2013 Slide Presentation (Prescription Drug Misuse)
The Skeeterhawk Experiment 2013 Slide Presentation (Prescription Drug Misuse)The Skeeterhawk Experiment 2013 Slide Presentation (Prescription Drug Misuse)
The Skeeterhawk Experiment 2013 Slide Presentation (Prescription Drug Misuse)Skeeterhawk
 
Baby Steps of Competition Law Jurisprudence in Pharmaceutical Sector - K.K. S...
Baby Steps of Competition Law Jurisprudence in Pharmaceutical Sector - K.K. S...Baby Steps of Competition Law Jurisprudence in Pharmaceutical Sector - K.K. S...
Baby Steps of Competition Law Jurisprudence in Pharmaceutical Sector - K.K. S...KK SHARMA LAW OFFICES
 
Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015
Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015
Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015Sathish Vemula
 
Pharma Uptoday Monthly Magazine Volume 21; Issue Dec 2015
Pharma Uptoday Monthly Magazine Volume 21; Issue Dec 2015Pharma Uptoday Monthly Magazine Volume 21; Issue Dec 2015
Pharma Uptoday Monthly Magazine Volume 21; Issue Dec 2015Sathish Vemula
 
Antitrust Aspects of Acquiring a Generic Drug Manufacturer
Antitrust Aspects of Acquiring a Generic Drug ManufacturerAntitrust Aspects of Acquiring a Generic Drug Manufacturer
Antitrust Aspects of Acquiring a Generic Drug ManufacturerNexsen Pruet
 
D-U-N-S & FEI Number
D-U-N-S & FEI NumberD-U-N-S & FEI Number
D-U-N-S & FEI NumberShikha Jain
 
Monthly Magazine - Pharma Uptoday Volume 9, Issue Dec 2014
Monthly Magazine - Pharma Uptoday Volume 9, Issue Dec 2014Monthly Magazine - Pharma Uptoday Volume 9, Issue Dec 2014
Monthly Magazine - Pharma Uptoday Volume 9, Issue Dec 2014Sathish Vemula
 

Mais procurados (14)

Country study: Availability of essential medicines
Country study: Availability of essential medicines Country study: Availability of essential medicines
Country study: Availability of essential medicines
 
Essential medicines in Hungary
Essential medicines in Hungary Essential medicines in Hungary
Essential medicines in Hungary
 
PSM Interchange 2014: Scott LaGanga, Welcome to the 2014 Interchange
PSM Interchange 2014: Scott LaGanga, Welcome to the 2014 InterchangePSM Interchange 2014: Scott LaGanga, Welcome to the 2014 Interchange
PSM Interchange 2014: Scott LaGanga, Welcome to the 2014 Interchange
 
Dave Aronberg: "Profiteers of Tragedy: Making Money Off America’s Opioid Addi...
Dave Aronberg: "Profiteers of Tragedy: Making Money Off America’s Opioid Addi...Dave Aronberg: "Profiteers of Tragedy: Making Money Off America’s Opioid Addi...
Dave Aronberg: "Profiteers of Tragedy: Making Money Off America’s Opioid Addi...
 
The Skeeterhawk Experiment 2013 Slide Presentation (Prescription Drug Misuse)
The Skeeterhawk Experiment 2013 Slide Presentation (Prescription Drug Misuse)The Skeeterhawk Experiment 2013 Slide Presentation (Prescription Drug Misuse)
The Skeeterhawk Experiment 2013 Slide Presentation (Prescription Drug Misuse)
 
Baby Steps of Competition Law Jurisprudence in Pharmaceutical Sector - K.K. S...
Baby Steps of Competition Law Jurisprudence in Pharmaceutical Sector - K.K. S...Baby Steps of Competition Law Jurisprudence in Pharmaceutical Sector - K.K. S...
Baby Steps of Competition Law Jurisprudence in Pharmaceutical Sector - K.K. S...
 
Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015
Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015
Pharma Uptoday - Monthly magazine; Volume 17, Issue Aug 2015
 
Pharma Uptoday Monthly Magazine Volume 21; Issue Dec 2015
Pharma Uptoday Monthly Magazine Volume 21; Issue Dec 2015Pharma Uptoday Monthly Magazine Volume 21; Issue Dec 2015
Pharma Uptoday Monthly Magazine Volume 21; Issue Dec 2015
 
Antitrust Aspects of Acquiring a Generic Drug Manufacturer
Antitrust Aspects of Acquiring a Generic Drug ManufacturerAntitrust Aspects of Acquiring a Generic Drug Manufacturer
Antitrust Aspects of Acquiring a Generic Drug Manufacturer
 
D-U-N-S & FEI Number
D-U-N-S & FEI NumberD-U-N-S & FEI Number
D-U-N-S & FEI Number
 
EMA CHAMPIX
EMA CHAMPIXEMA CHAMPIX
EMA CHAMPIX
 
Johson & johnson baby powder
Johson &  johnson baby powder Johson &  johnson baby powder
Johson & johnson baby powder
 
Monthly Magazine - Pharma Uptoday Volume 9, Issue Dec 2014
Monthly Magazine - Pharma Uptoday Volume 9, Issue Dec 2014Monthly Magazine - Pharma Uptoday Volume 9, Issue Dec 2014
Monthly Magazine - Pharma Uptoday Volume 9, Issue Dec 2014
 
Counterfeit Drugs in America: 2017 Overview
Counterfeit Drugs in America: 2017 OverviewCounterfeit Drugs in America: 2017 Overview
Counterfeit Drugs in America: 2017 Overview
 

Semelhante a Pharma & Biotech - Patent Litigation Report 2014 - MaxVal Group, Inc

ICIC 2014 Patent Landscape Analysis as a Tool for Public Policies Adjustment:...
ICIC 2014 Patent Landscape Analysis as a Tool for Public Policies Adjustment:...ICIC 2014 Patent Landscape Analysis as a Tool for Public Policies Adjustment:...
ICIC 2014 Patent Landscape Analysis as a Tool for Public Policies Adjustment:...Dr. Haxel Consult
 
Generic Drugs and Biosimilars
Generic Drugs and BiosimilarsGeneric Drugs and Biosimilars
Generic Drugs and BiosimilarsMichael Swit
 
Agenda- Device IP Patent Conference
Agenda- Device IP Patent ConferenceAgenda- Device IP Patent Conference
Agenda- Device IP Patent ConferenceRachel Starnes
 
ZMPCML041000.13.01 FDA Approved (registration information)
ZMPCML041000.13.01 FDA Approved (registration information)ZMPCML041000.13.01 FDA Approved (registration information)
ZMPCML041000.13.01 FDA Approved (registration information)Painezee Specialist
 
Final enforcement of biologics related patent under bpcia done
Final enforcement of biologics related patent under bpcia doneFinal enforcement of biologics related patent under bpcia done
Final enforcement of biologics related patent under bpcia doneVikram Jeet Singh
 
The Clinical Trials Business
The Clinical Trials BusinessThe Clinical Trials Business
The Clinical Trials BusinessReportLinker.com
 
Regulatory guidance and guidelines for filing and approval for biologics
Regulatory guidance and guidelines for filing and approval for biologicsRegulatory guidance and guidelines for filing and approval for biologics
Regulatory guidance and guidelines for filing and approval for biologicsNimmiRoy
 
The PTAB May Be Taking a More Balanced Approach in Biotech and Pharmaceutical...
The PTAB May Be Taking a More Balanced Approach in Biotech and Pharmaceutical...The PTAB May Be Taking a More Balanced Approach in Biotech and Pharmaceutical...
The PTAB May Be Taking a More Balanced Approach in Biotech and Pharmaceutical...Knobbe Martens - Intellectual Property Law
 
Data integrity - Regulatory Perspective and Challenges:
Data integrity - Regulatory Perspective and Challenges: Data integrity - Regulatory Perspective and Challenges:
Data integrity - Regulatory Perspective and Challenges: santoshnarla
 
Next-Generation Superfruits
Next-Generation SuperfruitsNext-Generation Superfruits
Next-Generation SuperfruitsReportsnReports
 
US Coagulation Testing Market: Innovative Technologies and Emerging Business ...
US Coagulation Testing Market: Innovative Technologies and Emerging Business ...US Coagulation Testing Market: Innovative Technologies and Emerging Business ...
US Coagulation Testing Market: Innovative Technologies and Emerging Business ...ReportsnReports
 
Expert witness view of fda regulated companies - information trial attorneys ...
Expert witness view of fda regulated companies - information trial attorneys ...Expert witness view of fda regulated companies - information trial attorneys ...
Expert witness view of fda regulated companies - information trial attorneys ...Joshua Sharlin, Ph.D.
 
ANDAs, OTCs, and Orphan Drugs
ANDAs, OTCs, and Orphan DrugsANDAs, OTCs, and Orphan Drugs
ANDAs, OTCs, and Orphan DrugsMichael Swit
 

Semelhante a Pharma & Biotech - Patent Litigation Report 2014 - MaxVal Group, Inc (20)

ICIC 2014 Patent Landscape Analysis as a Tool for Public Policies Adjustment:...
ICIC 2014 Patent Landscape Analysis as a Tool for Public Policies Adjustment:...ICIC 2014 Patent Landscape Analysis as a Tool for Public Policies Adjustment:...
ICIC 2014 Patent Landscape Analysis as a Tool for Public Policies Adjustment:...
 
Generic Drugs and Biosimilars
Generic Drugs and BiosimilarsGeneric Drugs and Biosimilars
Generic Drugs and Biosimilars
 
Usfda
UsfdaUsfda
Usfda
 
Agenda- Device IP Patent Conference
Agenda- Device IP Patent ConferenceAgenda- Device IP Patent Conference
Agenda- Device IP Patent Conference
 
ZMPCML041000.13.01 FDA Approved (registration information)
ZMPCML041000.13.01 FDA Approved (registration information)ZMPCML041000.13.01 FDA Approved (registration information)
ZMPCML041000.13.01 FDA Approved (registration information)
 
Final enforcement of biologics related patent under bpcia done
Final enforcement of biologics related patent under bpcia doneFinal enforcement of biologics related patent under bpcia done
Final enforcement of biologics related patent under bpcia done
 
The Clinical Trials Business
The Clinical Trials BusinessThe Clinical Trials Business
The Clinical Trials Business
 
Regulatory guidance and guidelines for filing and approval for biologics
Regulatory guidance and guidelines for filing and approval for biologicsRegulatory guidance and guidelines for filing and approval for biologics
Regulatory guidance and guidelines for filing and approval for biologics
 
The PTAB May Be Taking a More Balanced Approach in Biotech and Pharmaceutical...
The PTAB May Be Taking a More Balanced Approach in Biotech and Pharmaceutical...The PTAB May Be Taking a More Balanced Approach in Biotech and Pharmaceutical...
The PTAB May Be Taking a More Balanced Approach in Biotech and Pharmaceutical...
 
Data integrity - Regulatory Perspective and Challenges:
Data integrity - Regulatory Perspective and Challenges: Data integrity - Regulatory Perspective and Challenges:
Data integrity - Regulatory Perspective and Challenges:
 
Next-Generation Superfruits
Next-Generation SuperfruitsNext-Generation Superfruits
Next-Generation Superfruits
 
Aker may 2014 investor presentation
Aker may 2014 investor presentationAker may 2014 investor presentation
Aker may 2014 investor presentation
 
US FDA Quality Metrics Technical Conformance Guide
US FDA  Quality Metrics Technical  Conformance GuideUS FDA  Quality Metrics Technical  Conformance Guide
US FDA Quality Metrics Technical Conformance Guide
 
Drug Administration GoAP - Shri BL Meena
Drug Administration GoAP - Shri BL MeenaDrug Administration GoAP - Shri BL Meena
Drug Administration GoAP - Shri BL Meena
 
Usfda sana 1
Usfda sana 1Usfda sana 1
Usfda sana 1
 
guide.pdf
guide.pdfguide.pdf
guide.pdf
 
US Coagulation Testing Market: Innovative Technologies and Emerging Business ...
US Coagulation Testing Market: Innovative Technologies and Emerging Business ...US Coagulation Testing Market: Innovative Technologies and Emerging Business ...
US Coagulation Testing Market: Innovative Technologies and Emerging Business ...
 
PGR article
PGR articlePGR article
PGR article
 
Expert witness view of fda regulated companies - information trial attorneys ...
Expert witness view of fda regulated companies - information trial attorneys ...Expert witness view of fda regulated companies - information trial attorneys ...
Expert witness view of fda regulated companies - information trial attorneys ...
 
ANDAs, OTCs, and Orphan Drugs
ANDAs, OTCs, and Orphan DrugsANDAs, OTCs, and Orphan Drugs
ANDAs, OTCs, and Orphan Drugs
 

Último

SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdfHongBiThi1
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismusChandrasekar Reddy
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024EwoutSteyerberg1
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationMedicoseAcademics
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.whalesdesign
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionkrishnareddy157915
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.kishan singh tomar
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...Shubhanshu Gaurav
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets barmohitRahangdale
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxkomalt2001
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyMedicoseAcademics
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxMAsifAhmad
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfHongBiThi1
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)kishan singh tomar
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptPradnya Wadekar
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE Mamatha Lakka
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Peter Embi
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfHongBiThi1
 

Último (20)

SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdfSGK ĐIỆN GIẬT ĐHYHN        RẤT LÀ HAY TUYỆT VỜI.pdf
SGK ĐIỆN GIẬT ĐHYHN RẤT LÀ HAY TUYỆT VỜI.pdf
 
American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...American College of physicians ACP high value care recommendations in rheumat...
American College of physicians ACP high value care recommendations in rheumat...
 
power point presentation of Clinical evaluation of strabismus
power point presentation of Clinical evaluation  of strabismuspower point presentation of Clinical evaluation  of strabismus
power point presentation of Clinical evaluation of strabismus
 
Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024Trustworthiness of AI based predictions Aachen 2024
Trustworthiness of AI based predictions Aachen 2024
 
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxationPhysiology of Smooth Muscles -Mechanics of contraction and relaxation
Physiology of Smooth Muscles -Mechanics of contraction and relaxation
 
Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...Rheumatoid arthritis Part 1, case based approach with application of the late...
Rheumatoid arthritis Part 1, case based approach with application of the late...
 
MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.MedMatch: Your Health, Our Mission. Pitch deck.
MedMatch: Your Health, Our Mission. Pitch deck.
 
EXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung functionEXERCISE PERFORMANCE.pptx, Lung function
EXERCISE PERFORMANCE.pptx, Lung function
 
Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.Different drug regularity bodies in different countries.
Different drug regularity bodies in different countries.
 
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
FDMA FLAP - The first dorsal metacarpal artery (FDMA) flap is used mainly for...
 
Role of Soap based and synthetic or syndets bar
Role of  Soap based and synthetic or syndets barRole of  Soap based and synthetic or syndets bar
Role of Soap based and synthetic or syndets bar
 
Basic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptxBasic structure of hair and hair growth cycle.pptx
Basic structure of hair and hair growth cycle.pptx
 
Female Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before PregnancyFemale Reproductive Physiology Before Pregnancy
Female Reproductive Physiology Before Pregnancy
 
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptxDNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
DNA nucleotides Blast in NCBI and Phylogeny using MEGA Xi.pptx
 
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdfSGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
SGK LEUKEMIA KINH DÒNG BẠCH CÂU HẠT HAY.pdf
 
High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)High-Performance Thin-Layer Chromatography (HPTLC)
High-Performance Thin-Layer Chromatography (HPTLC)
 
ayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologypptayurvedic formulations herbal drug technologyppt
ayurvedic formulations herbal drug technologyppt
 
BENIGN BREAST DISEASE
BENIGN BREAST DISEASE BENIGN BREAST DISEASE
BENIGN BREAST DISEASE
 
Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024Clinical Research Informatics Year-in-Review 2024
Clinical Research Informatics Year-in-Review 2024
 
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdfSGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
SGK RỐI LOẠN TOAN KIỀM ĐHYHN RẤT HAY VÀ ĐẶC SẮC.pdf
 

Pharma & Biotech - Patent Litigation Report 2014 - MaxVal Group, Inc

  • 2. Pharma & Biotech patent litigation analysis 2 0 100 200 300 400 500 600 700 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 No. of cases Filed No. of cases Closed Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 No. of cases filed 166 140 179 294 283 328 424 381 451 622 584 No. of cases closed 109 118 119 206 245 278 343 417 422 535 605 PHARMA & BIOTECH PATENT LAWSUIT OVERVIEW 2004-2014
  • 3. Pharma & Biotech patent litigation analysis 3 Year 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 Pharma & Biotech Patent Lawsuits Filed 166 140 179 294 283 328 424 381 451 622 584 Total Patent Lawsuits Filed 2810 2565 2636 2794 2643 2580 3354 3907 5466 6107 5016 PHARMA & BIOTECH VS. OVERALL LITIGATION 0 1000 2000 3000 4000 5000 6000 7000 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 No. of Pharma & Biotech Patent Lawsuits Filed Total no. of Patent Lawsuits Filed
  • 4. Pharma & Biotech patent litigation analysis 4 6% 5% 7% 11% 11% 13% 13% 10% 8% 10% 12% 0% 2% 4% 6% 8% 10% 12% 14% 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 PERCENTAGE OF PHARMA & BIOTECH LITIGATION CASES 2004-2014
  • 5. Pharma & Biotech patent litigation analysis 5 0 5 10 15 20 25 30 35 40 45 50 Top plaintiff No. of cases Novartis Pharmaceuticals Corp. 47 Otsuka Pharmaceutical Co., Ltd. 35 AstraZeneca AB 32 Pfizer, Inc. 30 The Tawnsaura Group, LLC 26 AbbVie, Inc. 22 Cephalon, Inc. 22 Thermolife International, LLC 22 Warner Chilcott Company, LLC 21 Eli Lilly and Company 19 TOP COMPANIES AS PLAINTIFF
  • 6. Pharma & Biotech patent litigation analysis 6 0 5 10 15 20 25 30 35 40 45 Top defendant No. of cases Mylan, Inc. 43 Watson Laboratories, Inc. 35 Actavis Elizabeth, LLC 30 Lupin, Ltd. 28 Sandoz, Inc. 26 Apotex Corp. 24 Amneal Pharmaceuticals, LLC 23 Par Pharmaceutical, Inc. 22 Aurobinda Pharma, Ltd. 19 Roxane Laboratories, Inc. 18 TOP COMPANIES AS DEFENDANT
  • 7. Pharma & Biotech patent litigation analysis 7 Following are the details of the court wise case filings by Pharma & Biotech companies in the year 2014 0 50 100 150 200 250 California Central California Northern Delaware Florida Southern Illinois Northern Indiana Southern Massachu setts Michigan Eastern New Jersey New York Southern Texas Eastern West Virginia Northern Utah Rest of the Courts No. of Cases 18 7 216 10 11 12 10 10 156 29 9 11 12 73 3% 1% 37% 2% 2% 2% 2% 2% 27% 5% 1% 2% 2% 12% COURT-WISE NEW CASES FILED IN 2014
  • 8. Pharma & Biotech patent litigation analysis 8 Following are the details of the court wise case closures by Pharma & Biotech companies in the year 2014 0 20 40 60 80 100 120 140 160 180 California Central California Northern California Southern Delaware Florida Southern Illinois Northern Indiana Southern Massachu setts Nevada New Jersey New York Southern Virginia Eastern Texas Eastern Rest of the Courts No. of Cases 50 13 19 162 11 10 8 13 8 113 40 43 23 92 8% 2% 3% 27% 2% 2% 1% 2% 1% 19% 7% 7% 4% 15% COURT-WISE CLOSED CASES IN 2014
  • 9. Pharma & Biotech patent litigation analysis 9 0 50 100 150 200 250 300 350 400 450 2014 Filed 2014 Closed Midwest 51 45 Northeast 422 341 South East 53 86 South West 16 34 West 42 99 REGION-WISE FILED & CLOSED CASES IN 2014
  • 10. Pharma & Biotech patent litigation analysis 10 0 20 40 60 80 100 120 140 160 180 200 Top Plaintiff Lawfirm 2014 cases 0 5 10 15 20 25 30 35 Top Defendant Lawfirm 2014 cases Plaintiff's Lawfirm No. of cases Morris, Nichols, Arsht & Tunnell, LLP 177 Mccarter & English, LLP 92 Pepper Hamilton, LLP 55 Ashby & Geddes 25 Saul Ewing, LLP 23 Shaw Keller, LLP 22 Fish & Richardson, PC 21 Newport Trial Group 19 Barnes & Thornburg, LLP 18 Robinson, Wettre & Miller, LLC 17 Defendant's Lawfirm No. of cases Potter Anderson & Corroon, LLP 31 Richards, Layton & Finger, PA 22 Young Conaway Stargatt & Taylor, LLP 19 Budd Larner, PC 15 Phillips, Goldman & Spence, PA 14 Connell Foley, LLP 13 Fish & Richardson, PC 9 Fox Rothschild, LLP 9 Hill Wallack, LLP 8 Saiber, LLC 8 TOP LAWFIRMS HANDLING PHARMA & BIOTECH LAWSUITS
  • 11. Pharma & Biotech patent litigation analysis 11 Please contact us at bd@maxval-ip.com for detailed/comprehensive reports which will also include the following analysis: • Outcome of closed cases • Settlements • Judgments • Dismissals • Transfer of cases • Damages • Injunctions • Winning and losing party • Cases appealed in Federal Circuit (CAFC) • ITC case details • Supreme court case details CONTACT US FOR DETAILED ANALYSIS
  • 12. Pharma & Biotech patent litigation analysis 12 MaxVal’s Patent Litigation Databank, Analytics & API  Litigation databank contains patent litigations filed since 1980.  67,000+ cases in databank with daily updates.  Fully searchable databases with information related to patent litigation from ECFs, PACER, ITC, etc.  Complaints, docket reports, patent, product details, and patent file histories.  Watch Case by patent, product, party, inventor etc.  Outcome of the closed cases, such as settlements, dismissals, judgments etc.  Litigation daily alerts.  Patent litigation data analytics & research services.  API - Integrate litigation data to your internal patent database/tools for analytics purpose and mapping of litigation information to your study. DATA SOURCE
  • 13. Pharma & Biotech patent litigation analysis MaxVal Group, Inc. 2251 Grant Road, Los Altos, CA 94024 Phone: 650-472-0644 Fax: 650-625-0294 Email: bd@maxval.com Web: www.maxval.com SEEWhat Else We Can Do For YOU 13 Need the full report? (or) Similar reports on patent litigation of your interest? Please contact us at bd@maxval.com

Notas do Editor

  1. Litigation analysis for Golden Bridge Technology